WINMARK CORP Insider Trading Activity
Winmark Corp director Lawrance A. Barbetta reported insider transactions involving the company’s common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Winmark Corp director Lawrance A. Barbetta reported insider transactions involving the company’s common stock. On 12/15/2025, he disposed of 649 shares of Winmark common stock and, on the same date, received a new non-employee director stock option to purchase 256 shares at an exercise price of $444.54 per share, exercisable starting 12/15/2026 and expiring 12/15/2035.
After this grant, Barbetta continues to hold multiple other director stock option awards on Winmark common stock, including options with an exercise price of $134.25 per share expiring 12/11/2027 and options with an exercise price of $261.32 per share expiring 12/13/2031. The newly reported options vest at a rate of 25% per year over four years, tying part of his compensation to Winmark’s long-term performance.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Non-Employee Director Stock Option (right to buy) | 256 | $444.54 | $114K |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Non-Employee Director Stock Option (right to buy) | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. 25% per year for four years.
AI-generated analysis. How Rhea-AI works. Not financial advice.
